Richard Scolyer

134PUBLICATIONS
586CO-AUTHORS
Medical mycologyMolecular targetsPredictive and prognostic markersNeurology and neuromuscular diseasesTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (134)

|May 21, 2026
CSF1R-dependent CD169-positive macrophages locally constrain melanoma growth in the skin.

|Mar 12, 2026
Molecular Profiling and Matched Targeted Therapy for Patients With Advanced Melanoma: Results From Part 1 of the MatchMEL Study.

Andrea Boutros, Matteo S Carlino, Raja Chaganti

|Jan 29, 2026
A randomised pilot trial of perioperative propranolol combined with celecoxib versus standard of care in stage III melanoma: The ProCel study protocol.

Katina J Selvaraj, Diona L Damian, J Guy Lyons

|Jan 28, 2026
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Lotte L Hoeijmakers, Petros Dimitriadis, Steven C M A Wijnen

|Dec 23, 2025
The Impact of Next-Generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Deep Penetrating Melanocytic Neoplasms.

Julia Edwin Jeyakumar, Afua Konadu Addo, Haya Mary Beydoun

|Oct 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Jennifer M Wiggins, Qiao Zhang, Yian Zhang

Pageof 23

Frequent Collaborators

49 joint publications

Georgina V Long

39 joint publications

Serigne N Lo

35 joint publications

John F Thompson

22 joint publications

James Wilmott